Fig. 2
From: Theranostics and contrast agents for magnetic resonance imaging
a T1-weighted MR images of Gd-DTPA-pullulan and Gd-DTPA-BMA. b Transverse T1-weighted MR images 1 h after IV injection of 0.05 (b-1), 0.025 (b-2), 0.125 mmol (b-3) Gd/kg of Gd-DTPA-pullulan and 0.05 mmol Gd/kg of Gd-DTPA-BMA (b-4). c In vitro contrast intensities of Gd-DTPA-Pullulan and Gd-DTPA-BMA. d Contrast intensities of liver parenchyma estimated using Image J software [30]